Profitelligence Profitelligence · Filing Ledger Sign up free →

29 filings · most recent first

THC 8-K Filings

Tenet Healthcare Reports Strong Q2 2026 Results And Raises Share Repurchase Tenet Healthcare Corporation Announces 2026 Annual Meeting Voting Results Tenet Healthcare Reports Strong Q1 2026 Financial Results Tenet Healthcare Corporation Announces Issuance Of New Senior Notes Tenet Healthcare Announces New Credit Agreement And Amendment To Letter Of Cio Of Tenet Healthcare To Retire Tenet Healthcare Appoints New Senior Vice President Controller Tenet Healthcare Reports Strong 2025 Financial Results And Provides 2026 Outlook Tenet Healthcare Completes Transaction With Commonspirit Health Resignation Of Board Member Stephen H Rusckowski From Tenet Healthcare Tenet Healthcare Announces Private Offering Of Senior Notes To Refinance Tenet Healthcare Reports Q3 2025 Results And Raises Fy 2025 Outlook Tenet Healthcare Reports Strong Q2 2025 Results And Raises Outlook Tenet Healthcare Promotes Lisa Y Foo To Chief Operating Officer Tenet Healthcare Shareholders Elect Directors And Approve Executive Compensation Tenet Healthcare Reports Strong Q1 2025 Financial Results Tenet Healthcare Reports Strong Q4 2024 Results And Provides 2025 Outlook Amendment Of Ceo Employment Agreement Tenet Healthcare Reports Strong Q3 2024 Financial Results Tenet Healthcare Announces Sale Of Five Alabama Hospitals For 910M Tenet Healthcare Announces Strong Q2 2024 Results And Raises Outlook Tenet Healthcares 2024 Annual Meeting Voting Results Announced Tenet Healthcare Reports Strong First Quarter 2024 Results And Raises 2024 Tenet Healthcare Completes Sale Of Six Hospitals In California Tenet Healthcare Announces Sale Of Two California Hospitals And New Revenue Tenet Healthcare Calls For Full Redemption Of 2026 Notes Tenet Healthcare Reports Strong Q4 2023 Financial Results And 2024 Outlook Tenet Healthcare Announces Completion Of Sale Of South Carolina Hospitals For Tenet Healthcare Announces Hospital Sales And Financial Guidance
THC full research: price, insiders, financials →